About usSign in
Status
ACTIVE
Global HQ
Grundy Center, United States
Countries of investment
  • USA
Investment stages
  • Seed
Industries
  • Technology
  • Consumer Goods
About
Aurum Ventures MKI is the Technology investment arm of Morris Kahn, focusing on the healthcare sector. They provide growth Capital and strategic support to startups in life sciences and healthcare, helping them mature into successful businesses.
Min check size
$500K
Max check size
$10M
Fund size
NPS

Investment Thesis

They Focus on investing in unique, cutting edge technologies that contribute to the wellbeing of mankind, particularly in the healthcare sector. They aim to invest in companies that have sound commercial propositions and provide valueadded growth Capital to exceptional entrepreneurs.
Lead investor
Co Invest
Number of exits
Preferred contact method

Portfolio

Beyeonics: Surgeoncentered visualization technologies

Polypid: Targeted drug delivery systems

Beta O2: Bioartificial pancreas for Type1 Diabetes

Zebra Medical Vision: AI tools for radiologists

Nucleix: Noninvasive molecular cancer diagnostics

VBL: Anticancer biopharmaceuticals

Precise Bio: 3D bioprinting for tissue engineering

Scopio Labs: Digitalmicroscopy platform

Carevature Medical: Minimally invasive spine surgery tools

KidneyCure: Cell therapies for Chronic Kidney Disease

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp